Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Strano

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Nature Structural & Molecular Biology|September 29, 2009
The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesisGiulia Fontemaggi, Stefania Dell'Orso, Daniela Trisciuoglio, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2010
Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohortEva S Schernhammer, Franco Berrino, Vittorio Krogh, et al.
Nature Communications|May 31, 2012
Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYCGiovanni Blandino, Mariacristina Valerio, Mario Cioce, et al.
Cancer Research|March 17, 2007
Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cellsLilach Weisz, Alexander Damalas, Michalis Liontos, et al.
Oncogene|January 10, 2018
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretomeSimona di Martino, Carla Azzurra Amoreo, Barbara Nuvoli, et al.
Carcinogenesis|November 11, 2017
MiRNA-513a-5p inhibits progesterone receptor expression and constitutes a risk factor for breast cancer: the hOrmone and Diet in the ETiology of breast cancer prospective studyPaola Muti, Sara Donzelli, Andrea Sacconi, et al.
Oncotarget|February 16, 2017
MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancerValeria Canu, Andrea Sacconi, Laura Lorenzon, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 20, 2022
Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trialPaola Muti, Andrea Sacconi, Claudio Pulito, et al.
Cell Death and Differentiation|November 24, 2020
Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferationValeria Canu, Sara Donzelli, Andrea Sacconi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 31, 2014
Downregulation of microRNAs 145-3p and 145-5p is a long-term predictor of postmenopausal breast cancer risk: The ORDET prospective studyPaola Muti, Andrea Sacconi, Ahmed Hossain, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Nature Structural & Molecular Biology|September 29, 2009
The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesisGiulia Fontemaggi, Stefania Dell'Orso, Daniela Trisciuoglio, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2010
Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohortEva S Schernhammer, Franco Berrino, Vittorio Krogh, et al.
Nature Communications|May 31, 2012
Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYCGiovanni Blandino, Mariacristina Valerio, Mario Cioce, et al.
Cancer Research|March 17, 2007
Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cellsLilach Weisz, Alexander Damalas, Michalis Liontos, et al.
Oncogene|January 10, 2018
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretomeSimona di Martino, Carla Azzurra Amoreo, Barbara Nuvoli, et al.
Carcinogenesis|November 11, 2017
MiRNA-513a-5p inhibits progesterone receptor expression and constitutes a risk factor for breast cancer: the hOrmone and Diet in the ETiology of breast cancer prospective studyPaola Muti, Sara Donzelli, Andrea Sacconi, et al.
Oncotarget|February 16, 2017
MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancerValeria Canu, Andrea Sacconi, Laura Lorenzon, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 20, 2022
Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trialPaola Muti, Andrea Sacconi, Claudio Pulito, et al.
Cell Death and Differentiation|November 24, 2020
Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferationValeria Canu, Sara Donzelli, Andrea Sacconi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 31, 2014
Downregulation of microRNAs 145-3p and 145-5p is a long-term predictor of postmenopausal breast cancer risk: The ORDET prospective studyPaola Muti, Andrea Sacconi, Ahmed Hossain, et al.
Pageof 12